Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthcare Services (HCSG) Cash from Investing Activities (2016 - 2025)

Healthcare Services (HCSG) has disclosed Cash from Investing Activities for 17 consecutive years, with $8.6 million as the latest value for Q4 2025.

  • On a quarterly basis, Cash from Investing Activities fell 60.72% to $8.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$11.0 million, a 281.96% decrease, with the full-year FY2025 number at -$11.0 million, down 281.96% from a year prior.
  • Cash from Investing Activities was $8.6 million for Q4 2025 at Healthcare Services, up from -$2.7 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $21.8 million in Q4 2024 to a low of -$27.8 million in Q2 2024.
  • A 5-year average of -$1.4 million and a median of -$1.3 million in 2022 define the central range for Cash from Investing Activities.
  • Biggest YoY gain for Cash from Investing Activities was 1676.85% in 2024; the steepest drop was 26283.96% in 2024.
  • Healthcare Services' Cash from Investing Activities stood at -$8.7 million in 2021, then surged by 96.63% to -$292000.0 in 2022, then plummeted by 373.63% to -$1.4 million in 2023, then surged by 1676.14% to $21.8 million in 2024, then plummeted by 60.72% to $8.6 million in 2025.
  • Per Business Quant, the three most recent readings for HCSG's Cash from Investing Activities are $8.6 million (Q4 2025), -$2.7 million (Q3 2025), and -$2.4 million (Q2 2025).